Sistema de Información Esencial en Terapéutica y Salud


Última actualización: 26/5/2020
SIETES contiene 93011 citas

 1 a 20 de 245 siguiente >>
Presentar resultados
Seleccionar todas
1. Cita con resumen
Pescador D. La terrible realidad de los esteroides anabolizantes. 2019:11 de mayo. [Ref.ID 103107]
2.Enlace a cita original Cita con resumen
Anónimo. Towards better patient care: drugs to avoid in 2019. Prescrire Int 2019;39:abril. [Ref.ID 103075]
3. Cita con resumen
Maier L, Pruteanu M, Kuhn M, Zeller G, Telzerow A, Anderson EE, Brochado AR, Fernandez KC, Dose H, Mori H, Patil KR, Bork P, Typas A. Extensive impact of non-antibiotic drugs on human gut bacteria. Nature 2018;555:29 de marzo. [Ref.ID 102577]
4. Cita con resumen
Anónimo. FDA announces list of off-patent drugs with no competition. DIA Daily 2017:1. [Ref.ID 101658]
5. Cita con resumen
Anónimo. Excès de poils d'origine médicamenteuse. Prescrire 2017;37:26. [Ref.ID 101367]
6.Enlace a cita original Cita con resumen
Martinez C, Suissa S, McGill J, Rietbrock S, Katholing A, Freedman B, Cohen AT, Handelsman DJ. Testosterone treatment and risk of venous thromboembolism: population based case-control study. BMJ 2016;355:i5968. [Ref.ID 101016]
8. Cita con resumen
Cunningham GR, Stephens-Shields AJ, Rosen RC, Wang C, Bhasin S, Matsumoto AM, Parsons JK, Gill TM, Molitch ME, Farrar JT, Cella D, Barrett-Connor E, Cauley JA, Cifelli D, Crandall JP, Ensrud KE, Gallagher L, Zeldow B, Lewis CE, Pahor M, Swerdloff RS, Hou X, Anton S, Basaria S, Diem SJ, Tabatabaie V, Ellenberg SS, Snyder PJ. Testosterone treatment and sexual function in older men with low testosterone levels. J Clin Endocrinol Metab 2016;101:3096-104. [Ref.ID 100597]
9. Cita con resumen
Townsley DM, Dumitriu B, Biancotto A, Weinstein B, Chen C, Hardy N, Mihalek AD, Lingala S, Kim YJ, Yao J, Jones E, Gochuico BR, Heller T, Wu CO, Calado RT, Scheinberg P, Young NS. Danazol treatment for telomere diseases. N Engl J Med 2016;374:1922-31. [Ref.ID 100340]
10. Cita con resumen
Snyder PJ, Bhasin S, Cunningham GR, Matsumoto AM, Stephens-Shields AJ, Cauley JA, Gill TM, Barrett-Connor E, Swerdloff RS, Wang C, Ensrud KE, Lewis CE, Farrar JT, Cella D, Rosen RC, Pahor M, Crandall JP, Molitch ME, Cifelli D, Dougar D, Fluharty L, Resnick SM, Storer TW, Anton S, Basaria S, Diem SJ, Hou X, Mohler ER, Parsons JK, Wenger NK, Zeldow B, Landis JR, Ellenberg SS, for the Testosterone Trials Investigators. Effects of testosterone treatment in older men. N Engl J Med 2016;374:611-24. [Ref.ID 100026]
11. Cita con resumen
Hampton T. Acetaminophen during pregnancy may affect offspring’s testes. JAMA 2015;314:16. [Ref.ID 99334]
12. Cita con resumen
Anónimo. FDA warns consumers not to use muscle growth product called Tri-Methyl Xtreme. U.S. Food and Drug Administration 2015:13 de abril. [Ref.ID 98946]
13. Cita con resumen
Anónimo. FDA to require warning on labels of testosterone products. DIA Daily 2015:4 de marzo. [Ref.ID 98821]
14. Cita con resumen
Anónimo. FDA advisory panel recommends curbs on testosterone medications. DIA Daily 2014:18 de septiembre. [Ref.ID 97925]
15. Cita con resumen
Lu-Yao GL, Albertsen PC, Moore DF, Shih W, Lin Y, DiPaola RS, Yao S-L. Fifteen-year survival outcomes following primary androgen-deprivation therapy for localized prostate cancer. JAMA Intern Med 2014;174:1460-7. [Ref.ID 97899]
16. Cita con resumen
Johansson JE, Andrén O, Andersson SO, Dickman PW, Holmberg L, Magnuson A, Adami HO. Natural history of early, localized prostate cancer. JAMA 2014;291:2713-9. [Ref.ID 97706]
17. Cita con resumen
Anónimo. Testosterone and cardiovascular risk. Med Lett Drugs Ther 2014;56:17. [Ref.ID 97419]
18. Cita con resumen
Evans-Brown M, Kimergård A, McVeigh J, Chandler M, Brandt SD. Is tamoxifen being sold to bodybuilders?. BMJ 2014;348:g1476. [Ref.ID 97330]
19. Cita con resumen
Anónimo. US drug regulator investigates safety of testosterone. BMJ 2014;348:2. [Ref.ID 97249]
20. Cita con resumen
Vigen R, O'Donnell CI, Barón AE, Grunwald GK, Maddox TM, Bradley SM, Barqawi A, Woning G, Wierman ME, Plomondon ME, Rumsfeld JS, Ho PM. Association of testosterone therapy with mortality, miocardial infarction, and stroke in men with low testosterone levels. JAMA 2013;310:1829-36. [Ref.ID 96689]
Seleccionar todas
 1 a 20 de 245 siguiente >>